Related Experiment Videos
[Where to look for progress in antithrombotic treatments?]
1Service d'hématologie biologique Hôtel-Dieu, Paris.
La Revue Du Praticien
|December 3, 1999
Summary
Thrombosis, a common cause of vascular events, necessitates new anticoagulant and antiplatelet therapies. Research focuses on novel drugs and combined treatments to overcome limitations of current antithrombotic agents.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Context:
- Thrombosis is a primary cause of arterial and venous vascular events.
- Current anticoagulant and antiplatelet therapies have limitations, driving the need for new treatments.
Purpose:
- To explore novel antithrombotic strategies and the clinical investigation of combined drug treatments.
- To guide the search for new antithrombotic agents by understanding thrombosis mechanisms.
- To consider the intensity of thrombogenic stimuli in developing novel therapeutic approaches.
Summary:
- The development of novel antithrombotic agents is crucial due to limitations in existing therapies.
- Combinations of antiplatelet drugs like aspirin with ticlopidine or clopidogrel are being investigated.
- New anticoagulant candidates targeting factors Xa, IIa, or VIIa, and enhancing vascular thromboresistance are emerging.
Impact:
- Advances in understanding thrombosis mechanisms inform the development of more effective antithrombotic drugs.
- Novel strategies aim to improve prevention of thrombotic episodes by addressing varying thrombogenic stimuli.
- The research landscape includes exploring combined antiplatelet therapies and new anticoagulant classes.